Investor Relations

         Nasdaq: PRPH

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

Company Overview

ProPhase Labs (NASDAQ: PRPH) (“ProPhase”) is a diversified biotech and genomics company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and also build a genomics data base to be used for further research including clinical studies.

Investor Contact Information


ProPhase Labs, Inc.
711 Stewart Ave
Suite 200
Garden City, NY 11530

Investor Relations

T: (516) 222-2560